Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-027902

Director sold 2,614 shares at an average $120.61 ($315,263)

  • Director acquired 2,614 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
COOPER GRAHAM K Director 2021-07-06 Option exercise +2,614 $17.00 $44,438 2,614 D
COOPER GRAHAM K Director 2021-07-06 Sale −614 $115.38 $70,843 2,000 D
COOPER GRAHAM K Director 2021-07-06 Sale −200 $116.41 $23,282 1,800 D
COOPER GRAHAM K Director 2021-07-06 Sale −200 $118.35 $23,670 1,600 D
COOPER GRAHAM K Director 2021-07-06 Sale −100 $119.68 $11,968 1,500 D
COOPER GRAHAM K Director 2021-07-06 Sale −200 $120.39 $24,078 1,300 D
COOPER GRAHAM K Director 2021-07-06 Sale −400 $121.59 $48,636 900 D
COOPER GRAHAM K Director 2021-07-06 Sale −100 $122.85 $12,285 800 D
COOPER GRAHAM K Director 2021-07-06 Sale −200 $123.76 $24,752 600 D
COOPER GRAHAM K Director 2021-07-06 Sale −300 $124.31 $37,293 300 D
COOPER GRAHAM K Director 2021-07-06 Sale −100 $126.51 $12,651 200 D
COOPER GRAHAM K Director 2021-07-06 Sale −100 $128.67 $12,867 100 D
COOPER GRAHAM K Director 2021-07-06 Sale −100 $129.38 $12,938 0 D
Derivatives
COOPER GRAHAM K Director 2021-07-06 Option exercise · Stock Option (Right to Buy) −2,614 16,561 D
Open-market sales · 2,614 sh · avg $120.61 · $315,263
Loading xslF345X03/doc4.xml…